<VariationArchive VariationID="17236" VariationName="NM_000089.4(COL1A2):c.4001_4004del (p.Asn1334fs)" VariationType="Deletion" Accession="VCV000017236" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="32275" VariationID="17236">
      <GeneList>
        <Gene Symbol="COL1A2" FullName="collagen type I alpha 2 chain" GeneID="1278" HGNC_ID="HGNC:2198" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="94394895" stop="94431227" display_start="94394895" display_stop="94431227" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="94023872" stop="94060543" display_start="94023872" display_stop="94060543" Strand="+" />
          </Location>
          <OMIM>120160</OMIM>
          <Haploinsufficiency last_evaluated="2012-10-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL1A2">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-10-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL1A2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000089.4(COL1A2):c.4001_4004del (p.Asn1334fs)</Name>
      <CanonicalSPDI>NC_000007.14:94430290:AAATAA:AA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="94430291" stop="94430294" display_start="94430291" display_stop="94430294" variantLength="4" positionVCF="94430290" referenceAlleleVCF="CAAAT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="94059603" stop="94059606" display_start="94059603" display_stop="94059606" variantLength="4" positionVCF="94059602" referenceAlleleVCF="CAAAT" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_2t1" sequenceAccession="LRG_2t1">
            <Expression>LRG_2t1:c.4001_4004del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007405.1" sequenceAccession="NG_007405" sequenceVersion="1" change="g.40733_40736del">
            <Expression>NG_007405.1:g.40733_40736del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.94059605_94059608del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.94059605_94059608del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.94430293_94430296del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.94430293_94430296del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000089.4" sequenceAccession="NM_000089" sequenceVersion="4" change="c.4001_4004del" MANESelect="true">
            <Expression>NM_000089.4:c.4001_4004del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000080.2" sequenceAccession="NP_000080" sequenceVersion="2" change="p.Asn1334fs">
            <Expression>NP_000080.2:p.Asn1334fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_2" sequenceAccession="LRG_2">
            <Expression>LRG_2:g.40733_40736del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA257748" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="120160.0005" DB="OMIM" />
        <XRef Type="rs" ID="72659345" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000089.4(COL1A2):c.4001_4004del (p.Asn1334fs) AND Osteogenesis imperfecta type III" Accession="RCV000018776" Version="31">
        <ClassifiedConditionList TraitSetID="5676">
          <ClassifiedCondition DB="MedGen" ID="C0268362">Osteogenesis imperfecta type III</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1984-11-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1984-11-10" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">6092353</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5676" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3679" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 3</ElementValue>
                <XRef ID="MONDO:0009804" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta, progressively deforming with normal sclerae</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type III</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Osteogenesis imperfecta type III</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+type+3/5458" DB="Genetic Alliance" />
                <XRef ID="385483009" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OI3</ElementValue>
                <XRef Type="MIM" ID="259420" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">COL1A1</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8695" />
                <XRef ID="8695" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">COL1A1/2 osteogenesis imperfecta (COL1A1/2-OI) is characterized by fractures with minimal or absent trauma, variable dentinogenesis imperfecta (DI), and, in adult years, hearing loss. The clinical features of COL1A1/2-OI represent a continuum ranging from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal dentition, normal stature, and normal life span. Fractures can occur in any bone but are most common in the extremities. DI is characterized by gray or brown teeth that may appear translucent, wear down, and break easily. COL1A1/2-OI has been classified into four types based on clinical presentation and radiographic findings. This classification system can be helpful in providing information about prognosis and management for a given individual. The four more common OI types are now referred to as follows: Classic non-deforming OI with blue sclerae (previously OI type I). Perinatally lethal OI (previously OI type II). Progressively deforming OI (previously OI type III). Common variable OI with normal sclerae (previously OI type IV).</Attribute>
                <XRef ID="NBK1295" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301472</ID>
                <ID Source="BookShelf">NBK1295</ID>
              </Citation>
              <Citation Type="general" Abbrev="EMQN, 2012">
                <ID Source="pmc">3234509</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2008">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_OsteogenesisImperfecta.pdf</URL>
                <CitationText>Orphanet Emergency Guidelines: Osteogenesis imperfecta (OI)</CitationText>
              </Citation>
              <XRef ID="216812" DB="Orphanet" />
              <XRef ID="666" DB="Orphanet" />
              <XRef ID="C0268362" DB="MedGen" />
              <XRef ID="MONDO:0009804" DB="MONDO" />
              <XRef Type="MIM" ID="259420" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="39059" SubmissionDate="2011-06-23" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="120160.0005_OSTEOGENESIS IMPERFECTA, TYPE III" title="COL1A2, EX1, FS_OSTEOGENESIS IMPERFECTA, TYPE III" />
        <ClinVarAccession Accession="SCV000039059" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1984-11-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with osteogenesis imperfecta of Sillence type III (259420), Pihlajaniemi et al. (1984) demonstrated a 4-nucleotide frameshift deletion in exon 1 which instigated the use of a new termination codon 4 nucleotides 3-prime to the original site.</Attribute>
              <Citation>
                <ID Source="PubMed">6092353</ID>
              </Citation>
              <XRef DB="OMIM" ID="259420" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL1A2" />
          </GeneList>
          <Name>COL1A2, EX1, FS</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX1, FS</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="120160.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">OSTEOGENESIS IMPERFECTA, TYPE III</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="39059" TraitType="Disease" MappingType="Name" MappingValue="OSTEOGENESIS IMPERFECTA, TYPE III" MappingRef="Preferred">
        <MedGen CUI="C0268362" Name="Osteogenesis imperfecta type III" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

